These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 2808189

  • 1. In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex.
    Hoffner SE, Kratz M, Olsson-Liljequist B, Svenson SB, Källenius G.
    J Antimicrob Chemother; 1989 Sep; 24(3):317-24. PubMed ID: 2808189
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.
    Bermudez LE, Inderlied CB, Kolonoski P, Wu M, Barbara-Burnham L, Young LS.
    Antimicrob Agents Chemother; 1996 Mar; 40(3):546-51. PubMed ID: 8851568
    [Abstract] [Full Text] [Related]

  • 4. In-vitro evaluation of clarithromycin, temafloxacin, and ethambutol in combination against Mycobacterium avium complex.
    Gevaudan MJ, Bollet C, Mallet MN, de Micco P.
    J Antimicrob Chemother; 1993 May; 31(5):725-30. PubMed ID: 8392998
    [Abstract] [Full Text] [Related]

  • 5. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE, Inderlied CB, Kolonoski P, Petrofsky M, Aralar P, Wu M, Young LS.
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
    Gevaudan MJ, Bollet C, Mallet MN, de Lamballerie X, Sambuc R, de Micco P.
    Pathol Biol (Paris); 1992 May; 40(5):443-9. PubMed ID: 1323093
    [Abstract] [Full Text] [Related]

  • 8. Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.
    Rastogi N, Goh KS, Bryskier A, Devallois A.
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2483-7. PubMed ID: 8913450
    [Abstract] [Full Text] [Related]

  • 9. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH, Huh HJ, Song DJ, Moon SM, Lee SH, Shin SY, Kim CK, Ki CS, Koh WJ, Lee NY.
    J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
    [Abstract] [Full Text] [Related]

  • 10. Electron microscopic analysis of Mycobacterium avium complex isolates exposed to ciprofloxacin, rifabutin, ethambutol and clarithromycin.
    Reisner BS, Woods GL, Popov VL.
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):270-5. PubMed ID: 9432376
    [Abstract] [Full Text] [Related]

  • 11. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
    Pellegrin I, Maugein J, Lapeyre C, Barbeau P, Leng B, Pellegrin JL.
    J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014.
    Lee MR, Chien JY, Huang YT, Liao CH, Shu CC, Yu CJ, Hsueh PR.
    Int J Antimicrob Agents; 2017 Jul; 50(1):35-40. PubMed ID: 28478210
    [Abstract] [Full Text] [Related]

  • 17. N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies.
    Klopman G, Fercu D, Renau TE, Jacobs MR.
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2637-43. PubMed ID: 8913479
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.